7Baggers
 BridgeBio (BBIO) Unveils Positive Results in ATTRibute-CM Study  GuruFocus Sun, 28 Sep 2025 21:38:59 GMT
 BridgeBio presented data from ATTRibute-CM study on acoramidis  TipRanks Sun, 28 Sep 2025 21:18:36 GMT
 The News That Could Stoke BridgeBio, Up 80% This Year  Investor's Business Daily Sun, 28 Sep 2025 15:15:00 GMT
 H.C. Wainwright Reiterates a Buy on BridgeBio Pharma (BBIO)  Yahoo Finance Wed, 24 Sep 2025 06:12:49 GMT
 wall street analysts are bullish on top healthcare picks  The Globe and Mail Tue, 23 Sep 2025 13:02:00 GMT
 strs ohio makes new investment in bridgebio pharma, inc. $bbio  MarketBeat Tue, 23 Sep 2025 07:35:24 GMT
 bridgebio pharma (nasdaq:bbio) earns buy rating from hc wainwright  MarketBeat Sat, 20 Sep 2025 02:48:45 GMT
 bridgebio pharma (nasdaq:bbio) earns buy rating from hc wainwright  MarketBeat Fri, 19 Sep 2025 07:00:00 GMT
 bridgebio doubled as its new drug drove growth in 2025  Finimize Wed, 17 Sep 2025 20:04:39 GMT
 fda letters flag oprah video, morgan freeman ad in crackdown  Bloomberg.com Tue, 16 Sep 2025 07:00:00 GMT
 hc wainwright & co. reiterates buy rating on bbio | bbio stock n  GuruFocus Mon, 15 Sep 2025 12:39:58 GMT
 bridgebio pharma, inc. $bbio shares sold by woodline partners lp  MarketBeat Sun, 14 Sep 2025 09:37:38 GMT
 bridgebio pharma, inc. $bbio shares sold by woodline partners lp  MarketBeat Sat, 13 Sep 2025 23:48:15 GMT
 bridgebio pharma (nasdaq:bbio) ceo sells $2,053,600.00 in stock  MarketBeat Sat, 13 Sep 2025 07:00:00 GMT
 bridgebio (bbio) challenges pfizer's attr-cm promotion tactics  GuruFocus Fri, 12 Sep 2025 13:55:41 GMT
 bridgebio price target raised to $82 from $72 at ubs  TipRanks Fri, 12 Sep 2025 13:20:48 GMT
 bridgebio pharma stock price target raised to $82 from $72 at ubs  Investing.com UK Fri, 12 Sep 2025 07:00:00 GMT
 ubs reaffirms their buy rating on bridgebio pharma (bbio)  The Globe and Mail Fri, 12 Sep 2025 01:18:00 GMT
 jefferies reaffirms their buy rating on bridgebio pharma (bbio)  The Globe and Mail Thu, 11 Sep 2025 17:18:00 GMT
 bridgebio stock maintains buy rating at ubs ahead of key trial data  Investing.com Thu, 11 Sep 2025 14:51:06 GMT
 bridgebio pharma, inc. $bbio shares sold by woodline partners lp  MarketBeat Thu, 11 Sep 2025 12:33:53 GMT
 bridgebio pharma (nasdaq:bbio) ceo neil kumar sells 40,000 shares  MarketBeat Thu, 11 Sep 2025 01:29:11 GMT
 transcript : bridgebio pharma, inc. - special call  MarketScreener Wed, 10 Sep 2025 13:35:53 GMT
 kumar, bridgebio pharma ceo, sells $4.1m in bbio stock  Investing.com Tue, 09 Sep 2025 00:24:06 GMT
 bridgebio stock maintains buy rating at h.c. wainwright on positive encaleret data  Investing.com Nigeria Mon, 08 Sep 2025 14:03:46 GMT
 Kumar, BridgeBio Pharma CEO, sells $4.1m in BBIO stock  Investing.com Mon, 08 Sep 2025 07:00:00 GMT
 bridgebio pharma (nasdaq:bbio) price target raised to $70.00  MarketBeat Mon, 08 Sep 2025 07:00:00 GMT
 ieq capital llc takes position in bridgebio pharma, inc. $bbio  MarketBeat Mon, 08 Sep 2025 07:00:00 GMT
 bridgebio announces results from phase 2 study of encaleret  TipRanks Sun, 07 Sep 2025 15:41:51 GMT
 bridgebio’s encaleret shows promise in hypoparathyroidism treatment  Investing.com Sat, 06 Sep 2025 19:04:27 GMT
 encaleret showed parathyroid hormone-independent  GlobeNewswire Sat, 06 Sep 2025 18:33:26 GMT
 quarry lp makes new investment in bridgebio pharma, inc. $bbio  MarketBeat Sat, 06 Sep 2025 07:00:00 GMT
 bridgebio pharma stock hits 52-week high at $52.85 by investing.com  Investing.com Nigeria Sat, 06 Sep 2025 01:19:47 GMT
 BridgeBio Pharma stock hits 52-week high at $52.85  Investing.com Fri, 05 Sep 2025 07:00:00 GMT
 comerica bank trims stake in bridgebio pharma, inc. $bbio  MarketBeat Fri, 05 Sep 2025 07:00:00 GMT
 published on: 2025-09-05 07:26:11  خودرو بانک Fri, 05 Sep 2025 03:55:48 GMT
 published on: 2025-09-04 06:09:36  Newser Thu, 04 Sep 2025 11:09:36 GMT
 published on: 2025-09-04 04:34:17  Newser Thu, 04 Sep 2025 09:34:17 GMT
 published on: 2025-09-03 23:15:15  Newser Thu, 04 Sep 2025 04:15:15 GMT
 bridgebio pharma (bbio) receives a rating update from a top analyst  The Globe and Mail Wed, 03 Sep 2025 14:22:00 GMT

BridgeBio Pharma, Inc
(NASDAQ:BBIO) 

BBIO stock logo

BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs inc...

Founded: 2015
IPO Price: $17 (Jun 27, 2019)
Full Time Employees: 369
CEO: Neil Kumar  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends